These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 21316835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
    Park JW, Jo WH.
    J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991
    [Abstract] [Full Text] [Related]

  • 4. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).
    Mihajlovic ML, Mitrasinovic PM.
    Biophys Chem; 2008 Aug; 136(2-3):152-8. PubMed ID: 18584938
    [Abstract] [Full Text] [Related]

  • 5. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
    Malaisree M, Rungrotmongkol T, Nunthaboot N, Aruksakunwong O, Intharathep P, Decha P, Sompornpisut P, Hannongbua S.
    Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
    [Abstract] [Full Text] [Related]

  • 6. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS, Wang SQ, Chou KC.
    Biochem Biophys Res Commun; 2007 Oct 19; 362(2):525-31. PubMed ID: 17707775
    [Abstract] [Full Text] [Related]

  • 7. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
    Wang SQ, Du QS, Chou KC.
    Biochem Biophys Res Commun; 2007 Mar 16; 354(3):634-40. PubMed ID: 17266937
    [Abstract] [Full Text] [Related]

  • 8. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A, Soliman ME.
    Drug Des Devel Ther; 2015 Mar 16; 9():4137-54. PubMed ID: 26257512
    [Abstract] [Full Text] [Related]

  • 9. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
    Kar P, Knecht V.
    J Phys Chem B; 2012 May 31; 116(21):6137-49. PubMed ID: 22553951
    [Abstract] [Full Text] [Related]

  • 10. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ, Du QS, Huang RB, Zhang DW, Chou KC.
    Biochem Biophys Res Commun; 2009 Aug 28; 386(3):432-6. PubMed ID: 19523442
    [Abstract] [Full Text] [Related]

  • 11. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
    Karthick V, Ramanathan K.
    Cell Biochem Biophys; 2014 Mar 28; 68(2):291-9. PubMed ID: 23794010
    [Abstract] [Full Text] [Related]

  • 12. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W.
    J Med Chem; 2014 Oct 23; 57(20):8445-58. PubMed ID: 25255388
    [Abstract] [Full Text] [Related]

  • 13. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
    Shu M, Lin Z, Zhang Y, Wu Y, Mei H, Jiang Y.
    J Mol Model; 2011 Mar 23; 17(3):587-92. PubMed ID: 20517627
    [Abstract] [Full Text] [Related]

  • 14. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.
    Yusuf M, Mohamed N, Mohamad S, Janezic D, Damodaran KV, Wahab HA.
    J Chem Inf Model; 2016 Jan 25; 56(1):82-100. PubMed ID: 26703840
    [Abstract] [Full Text] [Related]

  • 15. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T, Rungrotmongkol T, Bren U, Frecer V, Stanislav M.
    J Chem Inf Model; 2009 Oct 25; 49(10):2323-32. PubMed ID: 19780597
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Shie JJ, Fang JM, Wang SY, Tsai KC, Cheng YS, Yang AS, Hsiao SC, Su CY, Wong CH.
    J Am Chem Soc; 2007 Oct 03; 129(39):11892-3. PubMed ID: 17850083
    [No Abstract] [Full Text] [Related]

  • 17. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Hurt AC, Lowther S, Middleton D, Barr IG.
    Antiviral Res; 2010 Sep 03; 87(3):361-6. PubMed ID: 20603155
    [Abstract] [Full Text] [Related]

  • 18. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
    Hill AW, Guralnick RP, Wilson MJ, Habib F, Janies D.
    Infect Genet Evol; 2009 Mar 03; 9(2):169-78. PubMed ID: 19022400
    [Abstract] [Full Text] [Related]

  • 19. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM.
    Biophys Chem; 2009 Mar 03; 140(1-3):35-8. PubMed ID: 19117662
    [Abstract] [Full Text] [Related]

  • 20. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T, Frecer V, De-Eknamkul W, Hannongbua S, Miertus S.
    Antiviral Res; 2009 Apr 03; 82(1):51-8. PubMed ID: 19428595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.